Skip to main content
Clinical Trials/ACTRN12609000691246
ACTRN12609000691246
Completed
Phase 3

In Indigenous children aged 6 months to 6 years with a diagnosis of acute otitis media, does Azithromycin given as a single dose (compared to 7 days of standard dose amoxicillin) result in a reduction in the proportion of children with signs of persistent disease after treatment?

HMRC0 sites330 target enrollmentAugust 12, 2009

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute otitis media in Indigenous children aged 6 months to 6 years
Sponsor
HMRC
Enrollment
330
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 12, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HMRC

Eligibility Criteria

Inclusion Criteria

  • Aboriginal. Betwen age 6 mo and 6 years. New diagnosis of acute otitis media (AOM) without perforation or AOM with perforation. Children willing to attend for follow\-up at day 6 to 11, and day 12\-21 for children with perforation.

Exclusion Criteria

  • Randomised previously in the same study. Received antibiotics in the previous 7 dyas. Current severe illness requiring intravenous or intramuscualar antibiotics within the next 7 days. Allergy to penicillin or azithromycin. Perforation in affected ear(s) greater than 2%

Outcomes

Primary Outcomes

Not specified

Similar Trials